OcuRx
OcuLightRx – Advanced LED Low Light Therapy LLLT
OcuLightRx – Advanced LED Low Light Therapy LLLT
Couldn't load pickup availability
14 DAY IN-OFFICE FREE TRIAL. ZERO INTEREST PAYMENT PLANS AVAILABLE - TO SCHEDULE A 15-MINUTE ZOOM DEMO, EMAIL - CONTACT@OCURX.COM
Boost Your Practice with OcuLightRx -
The OcuLightRx Low-Level Light Therapy (LLLT) Device can enhance your practice by delivering standalone or complementary dry eye treatment and more, at a fraction of the cost of other devices and offers easy-to-use functionality.
OcuLightRx offers photobiomodulation (PBM), a non-thermal approach that uses specific light wavelengths to treat many different eye conditions like Dry Eye, MGD, AMD, Tear film Stability, Styes, Demodex, and Blepharitis.
Core Features - Clinically Proven Wavelengths:
Red Light (630-660nm) - uses wavelengths to stimulate meibomian glands, reduce inflammation, and enhance tear film stability. Many patients report relief after just a few 10-to 15-minute sessions. Red light therapy targets mitochondrial dysfunction in ocular cells, boosting ATP (energy) production. This enhances the health of cells in the cornea, conjunctiva, and meibomian glands, supporting tissue repair and improving overall ocular surface health. This mechanism is particularly beneficial for addressing the root causes of dry eye.
Blue Light (405-470nm) - is Antimicrobial, reducing the bacterial load on eyelid margins for Meibomian Gland Dysfunction (MGD), and can also treat blepharitis, styes, and demodex.
Multi Wavelength Light (Yellow, Red and Near Infrared 590, 660, and 850 nm) -
The OculightRx offers a transformative approach to dry AMD care through its non-invasive, light-based photobiomodulation therapy, which ensures patient comfort while effectively targeting mitochondrial dysfunction in the retina—a key driver of dry AMD. By utilizing multiwavelength technology with three distinct wavelengths, it optimizes retinal cell function, leading to improved visual acuity and better overall retinal health. This targeted treatment not only addresses the root cause of dry AMD but also promotes sustained patient outcomes, making it a preferred choice for both patients and physicians seeking innovative, evidence-based solutions.
Backed by rigorous clinical trials like LIGHTSITE III and its extension LIGHTSITE IIIB. https://www.ophthalmologytimes.com/view/arvo-2025-update-on-the-lightsite-iii-study-in-amd
Near-Infrared Light (850nm) - Using PBM the 850nm wavelengths penetrate deeply into eyelid tissues to stimulate cellular repair, reduce inflammation, and enhance tear production, providing relief for dry eye symptoms. This non-invasive treatment works by boosting mitochondrial energy production (ATP) in meibomian glands and surrounding tissues, improving gland function and lipid layer quality in the tear film. Clinical studies show that 850 nm NIR therapy can increase tear breakup time (TBUT) by 20-30%, reduce ocular surface disease index (OSDI) scores by up to 40%, and promote anti-inflammatory effects, alleviating burning and grittiness.
-
Adjustable Settings: Customize intensity and duration for individual protocols.
- Evidence-Based: Backed by clinical research for reliable results.
Why Choose OcuLightRx
- Easy Integration: Intuitive design, fits existing workflows.
- Durable: Built for frequent professional use.
- Trusted Globally: Used worldwide for skin, pain, and recovery.
- Enhanced Outcomes: Boosts RF/IPL results for happier patients.
Rapid Return on Investment
- High Revenue: Just 5 weekly treatments at $250 could generate $65,000 annually.
- Upsell Potential: Enhances RF/IPL treatments, increasing per-patient revenue.
- Scalable: Quick 10–15 minute sessions maximize patient experience.
Studies of Low-Level Light (LLLT) Therapy for Dry Eye:
1. Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial
2. A randomized controlled study evaluating outcomes of intense pulsed light and low-level light therapy for treating meibomian gland dysfunction and evaporative dry eye
3. Intense Pulse Light Combined With Low-Level Light Therapy in Dry Eye Disease: A Systematic Review
Customizable Treatment Modes
Choose from pre-set programs tailored for specific concerns, or manually adjust intensity and wavelength combinations to suit your needs.
Ergonomic, Portable Design
Lightweight and foldable, its adjustable panels allow for targeted-area treatments.
Smart Timer
Keep track of your sessions effortlessly with the integrated smart timer.
What’s in the Box?
- OcuLightRx LED Therapy Device
- Adjustable Stand
- Protective Eye Goggles
- Charging Adapter & Cable
- User Manual & Quick Start Guide
Specifications
- Wavelengths: Red (630-660nm), Blue (405-470nm), Near-Infrared (850nm) Yellow (590nm)
- Power Output: Up to 100mW/cm²
* 14 DAY FREE TRIAL INCLUDES FREE OUTBOUND SHIPPING - RETURN SHIPPING COST IS CUSTOMER'S RESPONSIBILITY.
Share
